Skip to content

2 cryptocurrencies to reach $1 billion market cap in 2024

2 cryptocurrencies to reach $1 billion market cap in 2024

Some low market-cap cryptocurrencies can present appealing risk-reward potential in the highly competitive and constantly shifting crypto landscape. In this article, Finbold has picked two assets that could reach $1 billion in market value in 2024.

These projects sometimes grow under the radar due to not being featured among the top 100 ranks. However, it is important to understand that low market-cap cryptocurrencies will face different risks than the bigger ones. For example, lower liquidity or underdeveloped ecosystems.

In this selection, Finbold looked to fundamental aspects of these projects, including decentralization, security, utility, and competitive advantages against higher capitalized coins.

Radix (XRD) to reach $1 billion market cap

First, Radix (XRD) is a layer-1 blockchain that serves as the infrastructure for decentralized finance (DeFi). Its native token currently has a $407,12 million capitalization, trading at $0.039 per token.

If Radix reaches a $1 billion market cap in 2024, its value will increase by 145%, with a similar effect on price. However, XRD has yearly supply inflation of approximately 2.5%, slightly impacting the price surge.

Interestingly, this is a relatively low supply inflation to Radix’s valuable competitors. For example, Solana (SOL) has over $45 billion in capitalization and an estimated yearly inflation of 17%.

Radix (XRD) market cap and price data. Source: CoinMarketCap

Recent tests by Radix creator Dan Hughes suggest the network will perform around 31,000 swaps per second in decentralized exchanges (DEX) after its next update.

Moreover, the project uses an asset-oriented token creation model that offers users more security against crypto wallet drains. These drains are known for affecting EVM-based smart contract platforms like Ethereum (ETH), Avalanche (AVAX), and BNB Chain (BNB).

All in all, the fundamental aspects of Radix could position XRD as a strong competitor with a fair market value above the $1 billion market cap.

Nano (XNO) could skyrocket in 2024

Another cryptocurrency far below the $1 billion market cap and with meaningful competitive advantages is Nano (XNO). Nano is a layer-1 peer-to-peer money network for efficient value transfers. As of writing, XNO trades at $1.11 with $148.43 million in capitalization.

If Nano reaches a $1 billion market cap in 2024, its value will increase by 574%, with an exact effect on price. Essentially, all units of XNO were fully distributed by 2017 and have been circulating ever since, without dilution. This would make Nano trade at $7.50 per unit, a relevant price resistance to consider.

Besides having no inflation, Nano’s protocol focus on simplicity, efficiency, and good user experience. On that note, its network has zero transaction fees, positively impacting user costs and development implementations. Additionally, Nano transactions are completely irreversible in half a second (500ms), on average.

Radix (XRD) market cap and price data. Source: CoinMarketCap

Its properties are aligned with what Robert Kiyosaki recently explained as his reasons for investing in Bitcoin (BTC) as an alternative to Gold. Offering cheaper value transfer of a scarce commodity. Elon Musk’s AI Grok also named XNO the most suitable cryptocurrency for payments on X.

All things considered, Nano has the potential to reach a $1 billion market cap in 2024 with the proper awareness of its capacities. From a competitive perspective, it offers more efficient transactions than Bitcoin, XRP, Dogecoin (DOGE), Litecoin (LTC), Bitcoin Cash (BCH), and others while keeping decentralization and security.

Nevertheless, the cryptocurrency market is still mostly experimental and uncertain. Radix and Nano would need a meaningful increase in demand for their solutions to meet these expectations, and nothing is guaranteed.

Investors must do their due diligence while maintaining caution and proper risk management strategies, especially when investing in low market-cap cryptocurrencies.

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.